Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Debt / NOTE 0.750%10/1
-
Unit price / market price
-
$1.18
-
Total 13F principal
-
$276,560,709
-
Principal change
-
-$47,308,291
-
Total reported value
-
$326,738,837
-
Number of holders
-
45
-
Value change
-
-$49,629,285
-
Number of buys
-
15
-
Number of sells
-
24
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 as of Q4 2014
As of 31 Dec 2014 BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 had 45 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $276,560,709 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included ADVENT CAPITAL MANAGEMENT /DE/, OAKTREE CAPITAL MANAGEMENT LP, MACKAY SHIELDS LLC, SHENKMAN CAPITAL MANAGEMENT INC, BlackRock Advisors LLC, JPMORGAN CHASE & CO, Invesco Ltd., BAKER BROS. ADVISORS LP, CREDIT SUISSE AG/, and ROYAL BANK OF CANADA.
This table shows 45 bond principal holders of the security as of 31 Dec 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.